Literature DB >> 10794429

Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice.

Z Lazarova1, R Hsu, R A Briggaman, K B Yancey.   

Abstract

Patients with one form of cicatricial pemphigoid have IgG autoantibodies directed against laminin 5 (alpha3beta3gamma2), an adhesion protein in epidermal basement membrane. Anti-laminin 5 autoantibodies are not found in patients with other skin or mucosal diseases and hence serve as a specific marker for this autoimmune blistering disorder. The demonstration that experimental and patient anti-laminin 5 IgG are pathogenic in animal models indicated that such autoantibodies are central to disease pathophysiology. To investigate further the role of antibody valence and complement in triggering lesion formation in vivo, rabbit anti-laminin 5 (or normal, control) Fab fragments were passively transferred to neonatal BALB/c mice. Mice receiving anti-laminin 5 Fab fragments developed, in a dose-related fashion, circulating anti-basement membrane antibodies, deposits of immunoreactive rabbit IgG (but not murine C3) in epidermal basement membranes, and subepithelial blisters of skin and mucous membranes. Such alterations were not observed in mice treated with equivalent concentrations of normal rabbit Fab fragments. These studies demonstrated that neither complement activation nor cross-linking of laminin 5 in epidermal basement membranes was required for induction of subepidermal blister formation in this animal model of a human autoimmune bullous disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794429     DOI: 10.1006/clim.2000.4845

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  6 in total

Review 1.  Complement and cutaneous autoimmune blistering diseases.

Authors:  Elizabeth Lessey; Ning Li; Luis Diaz; Zhi Liu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  Laminin 332 deposition is diminished in irradiated skin in an animal model of combined radiation and wound skin injury.

Authors:  M M Jourdan; A Lopez; E B Olasz; N E Duncan; M Demara; W Kittipongdaja; B L Fish; M Mäder; A Schock; N V Morrow; V A Semenenko; J E Baker; J E Moulder; Z Lazarova
Journal:  Radiat Res       Date:  2011-08-19       Impact factor: 2.841

3.  Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid.

Authors:  Roxana Chiorean; Sorina Danescu; Oana Virtic; Mayson B Mustafa; Adrian Baican; Annette Lischka; Takashi Hashimoto; Yoshinobu Kariya; Manuel Koch; Cassian Sitaru
Journal:  Orphanet J Rare Dis       Date:  2018-07-06       Impact factor: 4.123

Review 4.  The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid.

Authors:  Mayumi Kamaguchi; Hiroaki Iwata
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

Review 5.  Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review.

Authors:  Gareth Edwards; Gilles F H Diercks; Marc A J Seelen; Barbara Horvath; Martijn B A van Doorn; Jeffrey Damman
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

Review 6.  The relevance of complement in pemphigoid diseases: A critical appraisal.

Authors:  Cristian Papara; Christian M Karsten; Hideyuki Ujiie; Enno Schmidt; Leon F Schmidt-Jiménez; Adrian Baican; Patricia C Freire; Kentaro Izumi; Katja Bieber; Matthias Peipp; Admar Verschoor; Ralf J Ludwig; Jörg Köhl; Detlef Zillikens; Christoph M Hammers
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.